IMMATICS NV (IMTX) Fundamental Analysis & Valuation

NASDAQ:IMTX • NL0015285941

Current stock price

10.53 USD
+0.28 (+2.73%)
At close:
10.53 USD
0 (0%)
After Hours:

This IMTX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. IMTX Profitability Analysis

1.1 Basic Checks

  • IMTX had negative earnings in the past year.
  • In the past year IMTX has reported a negative cash flow from operations.
  • In multiple years IMTX reported negative net income over the last 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: IMTX reported negative operating cash flow in multiple years.
IMTX Yearly Net Income VS EBIT VS OCF VS FCFIMTX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M -200M

1.2 Ratios

  • IMTX's Return On Assets of -34.93% is fine compared to the rest of the industry. IMTX outperforms 60.73% of its industry peers.
  • With a decent Return On Equity value of -40.58%, IMTX is doing good in the industry, outperforming 68.28% of the companies in the same industry.
Industry RankSector Rank
ROA -34.93%
ROE -40.58%
ROIC N/A
ROA(3y)-17.1%
ROA(5y)-19.11%
ROE(3y)-27.14%
ROE(5y)-90.19%
ROIC(3y)N/A
ROIC(5y)N/A
IMTX Yearly ROA, ROE, ROICIMTX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200 -300

1.3 Margins

  • IMTX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IMTX Yearly Profit, Operating, Gross MarginsIMTX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400 -600 -800

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. IMTX Health Analysis

2.1 Basic Checks

  • IMTX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for IMTX has been increased compared to 1 year ago.
  • IMTX has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, IMTX has a worse debt to assets ratio.
IMTX Yearly Shares OutstandingIMTX Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
IMTX Yearly Total Debt VS Total AssetsIMTX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

  • IMTX has an Altman-Z score of 7.14. This indicates that IMTX is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 7.14, IMTX is in the better half of the industry, outperforming 77.56% of the companies in the same industry.
  • A Debt/Equity ratio of 0.03 indicates that IMTX is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.03, IMTX is in line with its industry, outperforming 44.49% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 7.14
ROIC/WACCN/A
WACC7.41%
IMTX Yearly LT Debt VS Equity VS FCFIMTX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M

2.3 Liquidity

  • A Current Ratio of 11.72 indicates that IMTX has no problem at all paying its short term obligations.
  • IMTX has a better Current ratio (11.72) than 84.14% of its industry peers.
  • IMTX has a Quick Ratio of 11.72. This indicates that IMTX is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Quick ratio value of 11.72, IMTX belongs to the best of the industry, outperforming 84.14% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 11.72
Quick Ratio 11.72
IMTX Yearly Current Assets VS Current LiabilitesIMTX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. IMTX Growth Analysis

3.1 Past

  • The earnings per share for IMTX have decreased strongly by -1180.00% in the last year.
  • Looking at the last year, IMTX shows a very negative growth in Revenue. The Revenue has decreased by -69.03% in the last year.
  • The Revenue has been growing by 9.05% on average over the past years. This is quite good.
EPS 1Y (TTM)-1180%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-167.44%
Revenue 1Y (TTM)-69.03%
Revenue growth 3Y-34.63%
Revenue growth 5Y9.05%
Sales Q2Q%-64.87%

3.2 Future

  • IMTX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.45% yearly.
  • Based on estimates for the next years, IMTX will show a very strong growth in Revenue. The Revenue will grow by 60.71% on average per year.
EPS Next Y2.06%
EPS Next 2Y1.92%
EPS Next 3Y3.09%
EPS Next 5Y12.45%
Revenue Next Year17.63%
Revenue Next 2Y21.7%
Revenue Next 3Y38.06%
Revenue Next 5Y60.71%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
IMTX Yearly Revenue VS EstimatesIMTX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M 1B
IMTX Yearly EPS VS EstimatesIMTX Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -2 -4

More info and screens

Find the best growth stocksShow best growing peers

0

4. IMTX Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for IMTX. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for IMTX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IMTX Price Earnings VS Forward Price EarningsIMTX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IMTX Per share dataIMTX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.92%
EPS Next 3Y3.09%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. IMTX Dividend Analysis

5.1 Amount

  • IMTX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

IMTX Fundamentals: All Metrics, Ratios and Statistics

IMMATICS NV

NASDAQ:IMTX (4/8/2026, 8:00:02 PM)

After market: 10.53 0 (0%)

10.53

+0.28 (+2.73%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-05
Earnings (Next)05-11
Inst Owners75.9%
Inst Owner Change0%
Ins Owners4.66%
Ins Owner Change0%
Market Cap1.41B
Revenue(TTM)48.27M
Net Income(TTM)-196.45M
Analysts87.06
Price Target18.87 (79.2%)
Short Float %5.04%
Short Ratio10.57
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)9.43%
Min EPS beat(2)-5.58%
Max EPS beat(2)24.43%
EPS beat(4)2
Avg EPS beat(4)-14.6%
Min EPS beat(4)-77.7%
Max EPS beat(4)24.43%
EPS beat(8)6
Avg EPS beat(8)45.65%
EPS beat(12)9
Avg EPS beat(12)30.5%
EPS beat(16)10
Avg EPS beat(16)18.31%
Revenue beat(2)1
Avg Revenue beat(2)23.92%
Min Revenue beat(2)-52.27%
Max Revenue beat(2)100.11%
Revenue beat(4)2
Avg Revenue beat(4)2.99%
Min Revenue beat(4)-66.37%
Max Revenue beat(4)100.11%
Revenue beat(8)6
Avg Revenue beat(8)70.49%
Revenue beat(12)8
Avg Revenue beat(12)42.36%
Revenue beat(16)10
Avg Revenue beat(16)34.13%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)3.03%
EPS NQ rev (3m)2.22%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.14%
Revenue NQ rev (1m)-23.94%
Revenue NQ rev (3m)-23.8%
Revenue NY rev (1m)-7.75%
Revenue NY rev (3m)-1.47%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 25.31
P/FCF N/A
P/OCF N/A
P/B 2.52
P/tB 2.53
EV/EBITDA N/A
EPS(TTM)-1.87
EYN/A
EPS(NY)-1.83
Fwd EYN/A
FCF(TTM)-1.58
FCFYN/A
OCF(TTM)-1.52
OCFYN/A
SpS0.42
BVpS4.17
TBVpS4.16
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -34.93%
ROE -40.58%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-17.1%
ROA(5y)-19.11%
ROE(3y)-27.14%
ROE(5y)-90.19%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 54.88%
Cap/Sales 14.1%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 11.72
Quick Ratio 11.72
Altman-Z 7.14
F-Score2
WACC7.41%
ROIC/WACCN/A
Cap/Depr(3y)205.87%
Cap/Depr(5y)162.75%
Cap/Sales(3y)27.34%
Cap/Sales(5y)20.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1180%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-167.44%
EPS Next Y2.06%
EPS Next 2Y1.92%
EPS Next 3Y3.09%
EPS Next 5Y12.45%
Revenue 1Y (TTM)-69.03%
Revenue growth 3Y-34.63%
Revenue growth 5Y9.05%
Sales Q2Q%-64.87%
Revenue Next Year17.63%
Revenue Next 2Y21.7%
Revenue Next 3Y38.06%
Revenue Next 5Y60.71%
EBIT growth 1Y-371.35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-20.72%
EBIT Next 3Y-24.72%
EBIT Next 5Y5.64%
FCF growth 1Y-5.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-11.77%
OCF growth 3YN/A
OCF growth 5YN/A

IMMATICS NV / IMTX Fundamental Analysis FAQ

What is the fundamental rating for IMTX stock?

ChartMill assigns a fundamental rating of 3 / 10 to IMTX.


Can you provide the valuation status for IMMATICS NV?

ChartMill assigns a valuation rating of 0 / 10 to IMMATICS NV (IMTX). This can be considered as Overvalued.


How profitable is IMMATICS NV (IMTX) stock?

IMMATICS NV (IMTX) has a profitability rating of 2 / 10.


What is the earnings growth outlook for IMMATICS NV?

The Earnings per Share (EPS) of IMMATICS NV (IMTX) is expected to grow by 2.06% in the next year.